In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium

Journal of Rheumatology

Volumn 24, Issue 3, 1997, Pages 430-435

  Asahara, Hiroshi ^a   Hasunuma, Tomoko ^a   Kobata, Tetsuji ^a   Inoue, Hajime ^b   Muller Ladner, Ulf ^c   Gay, Steffen ^c   Sumida, Takayuki ^a   Nishioka, Kusuki ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c UNIVERSITY OF ALABAMA   (United States)

Author keywords

apoptosis; Fas antigen; Fas ligand; protooncogenes; rheumatoid arthritis

Indexed keywords

FAS ANTIGEN;

ADULT; APOPTOSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROTO ONCOGENE; RHEUMATOID ARTHRITIS; SYNOVIUM;

AGED; ANTIGENS, CD95; APOPTOSIS; ARTHRITIS, RHEUMATOID; FAS LIGAND PROTEIN; FEMALE; HUMANS; MALE; MEMBRANE GLYCOPROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; RNA, MESSENGER; SYNOVIAL MEMBRANE;

EID: 0030951570     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Gay S, Gay RE, Koopman WJ: Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: Two cellular mechanisms explain joint destruction? Ann Rheum Dis 1993;52:39-47.
2. Asahara H, Asanuma M, Ogawa N, Nishibayashi S, Inoue H: High DNA-binding activity of transcription factor NF-kB in synovial membranes of patients with rheumatoid arthritis. Biochem Mol Biol Int 1995;37:827-32.
3. Müller-Ladner U, Kriegsmann J, Gay RE, Gay S: Oncogenes in rheumatoid arthritis. Rheum Dis Clin North Am 1995;19:489-503.
4. Wyllie AH, Rose KA, Morris RG, Steel CM, Foster E, Spandidos DA: Rodent fibroblast tumors expressing human myc and ras genes: Growth, metastasis, and endogenous oncogene expression. Br J Cancer 1989;56:251-9.
5. Wang E, Lee MJ, Pandey S: Control of fibroblast senescence and activation of programmed cell death. J Cell Biochem 1994;54:432-9.
6. Nakajima T, Aono H, Hasunuma T, et al: Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocyte. Arthritis Rheum 1995;38:485-91.
7. Fujisawa K, Asahara H, Okamoto K, et al: Therapeutic effect of the anti-Fas antibody on arthritis in HTLV-1 tax transgenic mice. J Clin Invest 1996;98:271-8.
8. Takahashi T, Tanaka M, Brannan CI, et al: Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 1994;76:969-76.
9. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-7.
10. Carson DA, Ribeiro JM: Apoptosis and disease. Lancet 1993;341:1251-4.
11. Fassbender HG: Histomorphologic basis of articular cartilage destruction in rheumatoid arthritis. Coll Relat Res 1983;3:141-55.
12. Arnett FC, Edworthy SM, Bloch DA: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
13. Müller-Ladner U, Kriegsmann J, Tschopp J, Gay RE, Gay S: Demonstration of granzyme A and perform messenger RNA in the synovium of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:477-84.
14. Gavrich Y, Sherman Y, Ben-Sasson SA: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol 1992;119:493-501.
15. Angel P, Karin M: The role of Jun, Fos and the AP-1 complex cell-proliferation and transformation. Biochim Biophys Acta 1991;1072:129-57.
16. Smeyne RJ, Vendrell M, Hayward M, et al: Continuous c-fos expression precedes programmed cell death in vivo. Nature 1995;363:166-9.
17. Asahara H, Hasunuma T, Kobata T, et al: Expression of Fas antigen and Fas ligand in the rheumatoid synovial tissues. Clin Immunol Immunopathol 1996;81:27-34.
18. Berke G: The CTL's kiss of death. Cell 1995;81:9-12.
19. Suda T, Okazaki T, Naito Y, et al: Expression of the Fas ligand in cells of T cell lineage. J Immunol 1995;154:3806-13.
20. Kägi D, Vagnaux F, Ledermann B, et al: Fas and perform pathway as major mechanisms of T cell-mediated cytotoxicity. Science 1994;265:528-30.
21. Young LH, Joag SV, Lin PY, et al: Expression of cytolytic mediators by synovial fluid lymphocytes in rheumatoid arthritis. Am J Pathol 1992;140:1261-8.
22. Griffiths GM, Alpert S, Lambert E, McGuire J, Weissman IL: Perform and granzyme A expression identifying cytolytic lymphocytes in rheumatoid arthritis. Proc Natl Acad Sci USA 1992;89:549-53.
23. Kummer JA, Tak PP, Brinkman B, et al: Expression of granzymes A and B in synovial tissue from patients with rheumatoid arthritis and osteoarthritis. Clin Immunol Immunopathol 1994;73:88-95.
24. Tak PP, Kummer JA, Hack CE, et al: Granzyme-positive cytotoxic cells are specifically increased in early rheumatoid synovial tissue. Arthritis Rheum 1994:31:1735-43.